Greenrise Global Brands Inc. Stocks

CA$ 0.01Last Updated 06.11.2025

Issuer Rating

Performance

Modest

Risk

Low

Recommendation

Sell

Market Cap

CA$ 183895.80677

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CA$ 0.01
Key Takeaways

Risk factor

Considerable default risk

Profitability factor

Very weak growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Greenrise Global Brands Inc., through its subsidiaries, operates as a pharmaceutical supplier of medical cannabis products to pharmacies in Germany. It offers a range of CBD products consisting of tinctures, sprays, oils, and skincare products through drugstores; and imports and sells EU-GMP medical and cosmetic cannabis products. The company was formerly known as AMP Alternative...

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks